Scherer Lena, Kuss Matthias, Nahm Werner
Karlsruhe Institute of Technology, Karlsruhe, Germany.
Fresenius Medical Care, Berlin, Germany.
Adv Kidney Dis Health. 2023 Jan;30(1):40-46. doi: 10.1053/j.akdh.2022.11.002.
Artificial intelligence technology is trending in nearly every medical area. It offers the possibility for improving analytics, therapy outcome, and user experience during therapy. In dialysis, the application of artificial intelligence as a therapy-individualization tool is led more by start-ups than consolidated players, and innovation in dialysis seems comparably stagnant. Factors such as technical requirements or regulatory processes are important and necessary but can slow down the implementation of artificial intelligence due to missing data infrastructure and undefined approval processes. Current research focuses mainly on analyzing health records or wearable technology to add to existing health data. It barely uses signal data from treatment devices to apply artificial intelligence models. This article, therefore, discusses requirements for signal processing through artificial intelligence in health care and compares these with the status quo in dialysis therapy. It offers solutions for given barriers to speed up innovation with sensor data, opening access to existing and untapped sources, and shows the unique advantage of signal processing in dialysis compared to other health care domains. This research shows that even though the combination of different data is vital for improving patients' therapy, adding signal-based treatment data from dialysis devices to the picture can benefit the understanding of treatment dynamics, improving and individualizing therapy.
人工智能技术在几乎每个医学领域都呈发展趋势。它为改善分析、治疗效果以及治疗过程中的用户体验提供了可能性。在透析领域,将人工智能用作治疗个体化工具的应用更多是由初创企业引领,而非老牌企业,并且透析领域的创新似乎相对停滞不前。技术要求或监管流程等因素固然重要且必要,但由于缺乏数据基础设施和未明确的审批流程,可能会减缓人工智能的实施。当前的研究主要集中在分析健康记录或可穿戴技术,以补充现有的健康数据。它几乎不使用治疗设备的信号数据来应用人工智能模型。因此,本文讨论了医疗保健中通过人工智能进行信号处理的要求,并将其与透析治疗的现状进行比较。它针对给定的障碍提供了解决方案,以利用传感器数据加速创新,打通对现有和未开发数据源的访问,并展示了透析中信号处理相对于其他医疗保健领域的独特优势。这项研究表明,尽管不同数据的结合对于改善患者治疗至关重要,但将来自透析设备的基于信号的治疗数据纳入其中有助于理解治疗动态,改善并实现治疗个体化。